SK C&C has signed a deal with Microsoft Korea for cooperation in the advancement of AI cerebral hemorrhage solutions. The former is planning to register its imaging solution on Microsoft Azure for its healthcare platform.
SK C&C said it inked the memorandum of understanding (MOU) with Microsoft Korea on Thursday, Feb. 2. It has partnered with the American tech firm so it can expand into the global market for digital healthcare solutions. The IT services unit of the SK Group is also aiming to strengthen the industry ecosystem through the deal.
As per The Korea Economic Daily, under the agreement, the Medical Insight Plus Cerebral Hemorrhage imaging medical solution that was developed by SK C&C will be filed under the Microsoft Azure Healthcare neuroradiology category which is the company's cloud platform that specializes in healthcare.
Once registered, medical clinics that would like to make use of the solution can simply buy it from the Azure Marketplace. Buyers will also be able to receive follow-up services on the platform. SK C&C will also jump into the global market by working with the in-country sales organization of Microsoft company.
"Starting with Asia and Oceania, we will actively seek out various solutions for the global healthcare market as well as customized digital IT service markets in the medical field," SK C&C's Healthcare Group's head, Yoon Dong Joon, said.
Korea Biomed Review stated that SK C&C's Medical Insight+ Brain Hemorrhage is an AI-based cerebral hemorrhage imaging solution that assesses brain CT scan images. The solution can complete the analysis within seconds. Thus, doctors are immediately informed about any bleeding or abnormalities detected. The company said that the accuracy of the software is more than 98%
SK C&C further stressed that the imaging solution software has the ability to identify even the smallest bleeding that can be missed by professional neuro-head and neck radiologists.


China to Boost Brazilian Soybean Imports in Early 2026 Amid Price Advantage
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions
Canada’s Trade Deficit Jumps in November as Exports Slide and Firms Diversify Away From U.S.
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Asian Stocks Waver as Trump Signals Fed Pick, Shutdown Deal and Tech Earnings Stir Markets
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations
Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Google Disrupts Major Residential Proxy Network IPIDEA
U.S. Stock Futures Edge Lower as Tech Earnings and Fed Decision Shape Market Sentiment
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 



